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Abstract
Background: Five large insecticide-treated net (ITN) programmes and two indoor residual
spraying (IRS) programmes were compared using a standardized costing methodology.
Methods: Costs were measured locally or derived from existing studies and focused on the
provider perspective, but included the direct costs of net purchases by users, and are reported in
2005 USD. Effectiveness was estimated by combining programme outputs with standard impact
indicators.
Findings: Conventional ITNs: The cost per treated net-year of protection ranged from USD 1.21
in Eritrea to USD 6.05 in Senegal. The cost per child death averted ranged from USD 438 to USD
2,199 when targeting to children was successful.
Long-lasting insecticidal nets (LLIN) of five years duration: The cost per treated-net year of
protection ranged from USD 1.38 in Eritrea to USD 1.90 in Togo. The cost per child death averted
ranged from USD 502 to USD 692.
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IRS: The costs per person-year of protection for all ages were USD 3.27 in KwaZulu Natal and
USD 3.90 in Mozambique. If only children under five years of age were included in the denominator
the cost per person-year of protection was higher: USD 23.96 and USD 21.63. As a result, the cost
per child death averted was higher than for ITNs: USD 3,933–4,357.
Conclusion: Both ITNs and IRS are highly cost-effective vector control strategies. Integrated ITN
free distribution campaigns appeared to be the most efficient way to rapidly increase ITN coverage.
Other approaches were as or more cost-effective, and appeared better suited to "keep-up"
coverage levels. ITNs are more cost-effective than IRS for highly endemic settings, especially if high
ITN coverage can be achieved with some demographic targeting.
Background
Prevention of malaria in highly endemic countries relies
largely on vector control through one of two main meth-
ods: insecticide treated (mosquito) nets (ITNs) and
indoor residual (house) spraying (IRS). Both methods are
known to be highly effective and current evidence suggests
they are very similar in their impact [1]. Given the increas-
ing availability of resources for malaria control, the Roll
Back Malaria Partnership (RBM) has set the ambitious tar-
get for 2010 of 80% protection of high-risk groups by a
"locally appropriate" vector control measure [2]. While
few countries were near this objective in 2007, substantial
progress has been made. Inevitably, this has been accom-
panied by vigorous debate as to the best way forward with
regard to the different implementation models for ITNs,
as well as the relative merits of ITNs versus IRS [3-8].
While the implementation of IRS is typically through ver-
tical programmes, available options for ITN implementa-
tion are more diverse.
Besides feasibility, sustainability and health impact, cost
is obviously an important factor in the choice between dif-
ferent strategic options. Unfortunately, little is known on
comparative costs and operational requirements for the
delivery of ITNs and IRS. Direct comparisons in single set-
tings in sub-Saharan Africa (SSA) have shown conflicting
results on cost per person protected using either control
method [9-11]. A comprehensive modelling study has
been conducted covering ITNs and IRS [12] and the
authors found overlapping cost-effectiveness ranges for
the two interventions. For ITNs, four studies have exam-
ined large-scale programmes using field data in The Gam-
bia, Malawi, Tanzania and Togo [13-16]. However, each
of these studies focused on only one strategy and method-
ological differences make direct comparisons difficult
[17]. With the scale up of ITN activities in several SSA
countries it has become possible to collect and analyse
such information for a range of settings. This was under-
taken for ITNs in five sub-Saharan countries, and for IRS
in two countries. The present work allows, for the first
time, a direct cost-effectiveness comparison between dif-
ferent ITN strategies and IRS implementation on a large
scale. Hence, this work provides a solid evidence base for
a discussion of malaria vector control strategies in the
most highly malarious areas of the world.
Methods
Programme selection
The ITN programmes were deliberately chosen to repre-
sent the major existing distribution strategies operating at
large or fully national scale in sub-Saharan Africa. At the
beginning of this research, few large-scale ITN pro-
grammes utilizing similar distribution systems existed,
thus the choice of a representative country for each strat-
egy was limited. The main exception was subsidized com-
mercial distribution, which was implemented in several
countries. Senegal was chosen for this category mainly to
increase representation of West African countries. The
strategies were defined using terminology derived from
Webster et al [18]: (1) free ITN delivery through public
sector health services and at the community level – Eritrea
[19,20]; (2) free public sector ITN delivery through inte-
grated vaccination campaigns – Togo [21]; (3) highly sub-
sidized mixed public-private sector ITN delivery through
routine services – Malawi [22]; (4) partially subsidized
private retail sector promotion – Senegal [23]; (5) par-
tially subsidized private retail sector promotion with a
partially subsidized, mixed public-private, routine serv-
ices voucher scheme – Tanzania [24]. Table 1 presents
programme details with regard to size, time frame, total
economic costs and the latest available coverage figures.
The ITN programmes also adopted different strategies for
the provision of re-treatments for existing nets: Eritrea –
free re-treatment through community level campaigns,
Malawi – commercial sector cost recovery sales in urban
areas, Senegal – partially subsidized private retail sector
promotion, and Tanzania – cost recovery private retail sec-
tor sale and free delivery to pregnant women at antenatal
care visits. Unfortunately, empirical cost evidence was
only available for a single country where long-lasting
insecticidal nets (LLINs) were introduced, doing away
with the need for re-treatment (Togo).
The two IRS programmes were chosen because they were
large African programmes and cost data were available for
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both. They represented: (1) a programme funded locally
(KwaZulu-Natal, South Africa) and (2) an international
intervention funded by donors and a public-private part-
nership (Lubombo Spatial Development Initiative –
LSDI, Southern Mozambique).
The full programme descriptions are available elsewhere
[25].
Costs
The data on costs were either collected retrospectively for
the purpose of the study from financial and operational
records (Eritrea, Tanzania, Senegal, Malawi), or taken
from raw data sets or published studies which could be
adapted to this framework (KwaZulu-Natal, Mozam-
bique, Malawi, Togo). The collection of cost data covered
different periods between 1996–2005 (Table 1).
Where possible, the ingredients approach was used:
inputs were identified, valued, and classified into activity
categories. Where this approach was not possible, either
because the information was deemed too sensitive (typi-
cally for salaries) or was not available in adequate detail,
aggregated expenditures were used. All costs were con-
verted to United States Dollars (USD) based on official
yearly average exchange rates for the period during which
the costs were incurred (excepting Togo where the
exchange rate for the month when most expenditure
occurred was used). All costs were adjusted for inflation to
2005 prices using the US gross domestic product deflator
[26]. Some costs were estimated using the WHO Choos-
ing Interventions which are Cost-Effective (WHO-
CHOICE) unit cost and activity database, specifically
those for public sector inputs in Tanzania [27]. No adjust-
ments for purchasing power have been made, and in some
cases this may result in problems of comparability across
countries due to differences in country specific price lev-
els.
Where possible, both financial and economic costs were
collected in order to both estimate the financing require-
ments for programmes and to examine their efficiency.
Financial costs represent purely monetary flows, while
economic costs represent the value (or opportunity cost)
of all resources necessary to implement a given interven-
tion. Only economic costs are presented here as they are
considered the appropriate tool for comparisons of pro-
gramme efficiency. Financial costs are available elsewhere
[25].
A modified provider perspective was used; travel or time
costs to users, or other household-level costs or cost sav-
ings have not been included. However, the direct costs of
net purchases incurred by users have been included where
the nets were partially subsidized or sold at full cost. Dou-
ble counting was avoided by excluding the provider costs
which were offset by these user fees. Details on included
costs are presented in Table 2.
Costing scenarios
The base case costing scenarios relied on the following set
of assumptions: a discount rate of 3% was applied to cap-
ital costs; nets were assumed to last for three years (physi-
cal lifetime), but the effect of initial treatment as well as of
subsequent re-treatments were assumed to provide only
one year of protection (protective lifetime) [28]; fifty per-
cent of the nets delivered were assumed to be used by chil-
dren under five years of age and only one child was
Table 1: Main characteristics of the ITN and IRS programmes that were reviewed.
Population 
covered
(millions)
Period Total number 
of nets
Total number of 
re-treatments
Total 
economic cost
(Mio USD)
Net coverage in children under 
five years
Any net ITN
ITN 
Programmes
Eritrea 2.9 2001–05 900,000 2,000,000 3.7 Nav 59
Togo 5.3 2004 900,000 0 6.5 Nav 54
Malawi 12.2 1999–05 4,700,000 500,000 15.7 38 36
Senegal 10.0 2000–05 750,000 250,000 6.2 14 7
Tanzania 35.7 2002–05 6,400,000 7,800,000 30.5 41 28
IRS 
Programmes
KwaZulu-
Natal
0.6 1997–99 300,000 
structures
2.2 High High
Mozambique 0.8 1999–01 150,000 
structures
1.0 > 95% 
structures
> 95% 
structures
Nav = not available. ITN = insecticide-treated net.
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assumed to sleep under each of these nets on a given
night. These are believed to be conservative assumptions
[19,29]. The cost of nets was based on the cost, insurance
and freight (c.i.f.) price of the nets or on the full retail
price paid by users plus any subsidies (direct or via vouch-
ers) as estimated by survey data (Senegal and Tanzania) or
key informant interviews and project records (Senegal and
Malawi). For IRS, it was assumed that the given number of
annual spraying rounds (one or two) protected an entire
household for one year, with perfect post-spraying com-
pliance (no re-plastering of walls). Reported coverage by
IRS was always very high, over 95% at the time of data col-
lection in Mozambique, though high levels of re-plaster-
ing have been reported in some IRS interventions (Table
1) [30,31].
Several alternative scenarios were also calculated. One
involved the delivery of conventional ITNs in Togo, where
only long-lasting insecticidal nets (LLINs) were actually
distributed. The other programmes distributed a majority
of conventional nets and therefore the costs and outputs
in Togo were recalculated assuming a net cost of only USD
3.00 instead of the USD 4.33 paid per LLIN [16,32]. Other
alternative scenarios estimated the potential impact of
LLIN use on the cost-effectiveness of the programmes.
These scenarios were estimated in two ways. The first
approach was simply to change the net parameters,
including physical lifetime (three or five years), protective
lifetime (three or five years) and cost (USD 5.00 to USD
7.00) to values believed to be representative of available
LLINs, while not changing the properties, costs or benefits
associated with re-treatments [31-34]. The second
approach used the same changes for the nets but removed
the benefits and commodity costs associated with re-treat-
ments. While it might be reasonable to expect that re-
treatments will not be delivered in a LLIN programme,
this dual approach was required due to difficulty in sepa-
rating management and other costs associated with re-
treatment. Thus, comparing the two approaches helped us
to identify biases in the comparison between programmes
due to different re-treatment approaches as well as to bet-
ter quantify the potential benefits from a shift to LLINs,
which would probably result in the discontinuation of
most re-treatment activities. One way sensitivity analysis
was conducted on all cost estimates.
Outputs
Two main output measures were used for ITN pro-
grammes: (1) number of nets delivered, and (2) number
of re-treatments performed. These measures were used to
calculate a third combined output measure: treated net
years of protection (TNY), assuming that either a re-treat-
ment or a new conventional ITN provided one potential
year of protection for anyone sleeping under the net. For
IRS programmes two related outputs have been measured:
(1) number of persons of any age protected, and (2)
number of under-five children protected. Both calcula-
tions were made by applying the reported coverage rates
to the total population of the sprayed areas – based on
census information adjusted for population growth
[35,36].
Table 2: Types of costs included in the analysis of the ITN and IRS programmes.
ITN Programmes IRS Programmes
Capital cost Buildings Buildings
Vehicles Vehicles
ITNs (retail cost & subsidies)1 Sprayers
Other equipment Other equipment
Start-up costs2
Recurrent cost Insecticide (when separable from nets) Insecticide
Personnel Personnel
Fuel/maintenance Fuel/maintenance
Management cost/training & meetings Management cost/training & meetings
Office/warehouse rental Office/warehouse rental
Supplies/overheads Supplies/overheads
Recurrent building costs Recurrent building costs
Advertising and promotion3 Basic evaluation and monitoring 
(excluding specific research costs)
Basic evaluation and monitoring 
(excluding specific research costs)
1Procurement costs in Eritrea and Togo, subsidies plus user payments in Senegal, Tanzania, and Malawi.
2Economic costs which arose before outputs of those programmes occurred; these costs apply in Tanzania, Senegal and Malawi; they accounted for 
fewer than 3% of total economic costs in all cases.
3Information, education and communication, health promotion, direct or indirect advertising and promotion subsidies or other similar activities.
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Outcomes
In order to combine cost data with public health impact,
two outcomes were considered. First, the impact of ITNs
and IRS on child mortality was estimated. Country-spe-
cific estimates were not available but robust impact esti-
mates are available for ITNs from a Cochrane review [37]:
ITN use in a high endemicity and high coverage situation
averts 5.5 child deaths per 1,000 child-years. For IRS, how-
ever, unbiased impact estimates are scarce and have not
been systematically reviewed. This is a recognized prob-
lem and a Cochrane review is currently investigating this
issue [38]. In the absence of a better data set for IRS, and
because the impact of ITNs and IRS was found to be sim-
ilar in the five available randomized comparisons [1,39],
the same estimate of impact for both ITNs and IRS (i.e. 5.5
child deaths averted per 1,000 child-years of use) was
applied.
Secondly, disability-adjusted life years (DALYs) averted,
discounted at 3%, were calculated based on years of life
lost due to malaria-specific child mortality. These calcula-
tions exclude: (1) DALYs due to disability, and (2) DALYs
lost in persons over five years of age. In highly endemic
areas the burden of malaria is largely dominated by mor-
tality in children under five years [40]. In addition, quan-
titative data on the effects of the two interventions are very
limited for older children and adults [40,41]. In areas of
low malaria transmission or epidemic-prone areas, the
burden of disease is more evenly spread over the different
age groups and these assumptions do not hold. All child
deaths were treated as infant deaths and assigned a value
of 33 DALYs lost for each death [42]. This is also a con-
servative choice as estimates based on deaths distributed
across children from one and four years of age would have
yielded a higher number of DALYs averted.
Cost-effectiveness calculations
In a final analysis, the cost per TNY (for ITNs) and per
child protected (for IRS) were combined with the impact
estimates to produce comparable cost-effectiveness ratios
for both interventions. For calculation of impact estimates
for ITNs, the number of treated net years (TNYs) delivered
was adjusted for net wastage and usage among children by
assuming that only 50% of delivered nets (or re-treat-
ments) would be used by under five children and that
only one child would sleep under each of these nets. These
assumptions are examined in the sensitivity analysis.
The full set of country-specific operational and costing
results is available in an unpublished report [25]; selected
results only are presented here.
Results
Tanzania and Malawi were the largest programmes and
also the most expensive ones, with a total economic cost
of 30.5 and 15.7 million dollars for the periods under
review (Table 1). All the ITN programmes were larger in
terms of population protected than the two IRS pro-
grammes. When the scale of the largest annual ITN deliv-
ery is compared to the size of the population at risk for the
particular country [43], Togo and Malawi had the highest
ITN to population ratios (1:6) and (1:8), respectively,
while Senegal had the lowest (1:30). According to the
most recent data available for each country, Eritrea had
the highest reported ITN usage rate among children under
five years of age, while Senegal had the lowest. Both IRS
programmes reported very high coverage rates in the tar-
geted areas.
Economic costs for conventional ITNs
Annualized economic costs per conventional ITN distrib-
uted varied from USD 3.23 in Togo (or USD 2.75 if the net
Table 3: Average annual economic costs for ITN and IRS programmes.
ITN programmes Average annual cost per 
ITN distributed
Average annual cost per 
TNY
Cost per death averted** Cost per DALY 
averted**
Eritrea 3.98 1.21 438/1,449 13/44
Togo 3.23 3.23 1,174 36
Togo* 2.75 2.75 998 30
Malawi 3.36 3.04 1,105/1,222 33/37
Senegal 8.05 6.05 2,199/2,926 67/89
Tanzania 4.80 2.17 788/1,745 24/53
IRS programmes Cost per person 
protected 
(whole population)
Cost per under-five child 
protected
Cost per death averted Cost per DALY averted
KwaZulu-Natal 3.27 23.96 4,357 132
Mozambique 3.90 21.63 3,933 119
*Assuming an average net cost of USD 3 instead of USD 4.33 (the actual cost incurred for LLINs by the campaign).
**In paired numbers the left value includes protection from re-treatment kits
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price is set to USD 3.00 instead of USD 4.33 – see meth-
ods) to USD 8.05 in Senegal (Table 3). Costs per treated
net year (TNY) were lower in some cases due to the inclu-
sion of re-treatment of existing nets, which offered addi-
tional years of full protection with low commodity costs
(approximately USD 0.30. Both measures (cost per ITN
and per TNY) include the cost of re-treatments. Hence, the
costs per TNY delivered by conventional ITN programmes
ranged from USD 1.21 in Eritrea to USD 6.05 in Senegal.
It is important to note that higher costs in Senegal were
driven to a large extent by higher net costs in the retail sec-
tor.
There were important differences in the composition of
costs for each programme. The percentage of the total cost
born by the programme providers ranged widely: Togo
100%, Eritrea 83%, Malawi 69%, Tanzania and Senegal
45%. When a pure provider perspective is taken by remov-
ing all costs paid directly by users of nets, the annualized
costs to the provider per net distributed were fairly similar
between sites (range USD 2.75–3.63; for detailed results
see [25].
Additional calculations for the year during which the pro-
gramme delivered the largest number of nets were not
substantially different from the cost data presented in
Table 3[25]. However, the programmes varied greatly in
scale (200,000 to approximately three million ITNs per
year) and this is likely to contribute to the observed differ-
ences in unit costs.
Economic costs for IRS
In both IRS programmes cost data were only available for
one or two years of operations, after the start of the pro-
grammes. As a result, it was not possible to measure start-
up costs. The annualized costs per person protected for
IRS were USD 3.27 in KwaZulu Natal and USD 3.90 in
Mozambique (Table 3). However, when only children
under five years were included in the denominator for IRS
(see methods section) the cost per under five child pro-
tected by IRS was substantially higher: USD 23.96 per
child protected in KwaZulu Natal and USD 21.63 in
Mozambique.
Sensitivity analysis: one way results
Sensitivity analysis was carried out on the main assump-
tions and parameters used to calculate cost to output and
cost-effectiveness ratios. Discount rate, physical lifetime
of nets and costs of insecticide or re-treatment kits all had
relatively small effects on the results, however, other
parameters were more important, and fit into two groups:
(1) those relating to net properties (cost or protective life-
time) and (2) those related to net usage. For programmes
involving retail net sales the attribution of commercial
sales to programme activities also played an important
role. All results were in the expected direction [25].
For the IRS programmes the discount rate also had rela-
tively little effect on the results of the analysis, as did a
change in the population growth rate. Several parameters
had larger effects on the results, especially the compliance
of the population with spraying. Additionally, the cost of
adding or removing one of the annual spray rounds or of
switching types of insecticides had large effects on the
cost-effectiveness of the programmes. Longer transmis-
sion seasons or shorter-lived insecticides would require
additional spray rounds. The same applies if, for political
or resistance reasons, a shorter-acting insecticide were
used; more spray rounds imply a higher cost (and poten-
tially higher refusal rates).
Sensitivity analysis: LLIN cost scenarios
Table 4 shows the annualized economic cost per unit
delivered for long-lasting insecticidal nets (LLINs) with
three years duration and a cost of USD 5.00. In most set-
tings, annualized costs per net distributed were higher
than for conventional nets because of the higher initial
purchase price. Senegal was the exception because the
commodity costs observed in the programme were much
higher than in other programmes. In Togo, the costs
changed little because the programme only delivered such
LLINs. The annualized delivery costs ranged from USD
3.47 in Togo to USD 7.75 in Eritrea. The cost per TNY was
Table 4: Average annual economic costs for ITN (3-year LLIN) programmes.
ITN programme Average annual cost per 
LLIN distributed*
Average annual cost per 
TNY*
Cost per death averted* Cost per DALY averted*
Eritrea 7.75/7.28 1.46/2.43 531/882 16/27
Togo 3.47 2.37 862 26
Malawi 5.18/4.50 2.19/2.04 798/743 24/23
Senegal 7.58 2.64/4.14 960/1,503 29/46
Tanzania 6.04/5.36 1.83/2.39 664/870 20/26
* In paired numbers the left value includes protection from re-treatment kits while the right value results from removing both protection and 
commodity costs related to re-treatment kits (see main text for details).
Assumes all nets are conventional ITNs. 2005 USD. TNY = treated net-year. DALY = disability-adjusted life year.
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lower than for conventional nets in most cases, ranging
from USD 1.46 in Eritrea to USD 2.64 in Senegal (when
re-treatments were dropped: USD 2.04 in Malawi to USD
4.14 in Senegal).
The annualized cost per delivered 5-year LLIN costing
USD 7.00 generally fell compared to the three-year sce-
nario, though the differences were not large (Table 5).
They ranged from USD 3.23 in Togo to USD 10.08 in Eri-
trea (when re-treatments are dropped: USD 3.23 in Togo
to USD 9.60 in Eritrea). The cost per TNY was also lower
than for conventional nets or for three-year LLINs, ranging
from USD 1.38 in Eritrea to USD 1.90 in Togo (when re-
treatments are dropped: USD 1.69 in Malawi to USD 3.25
in Senegal).
Cost-effectiveness of ITNs, LLINs and IRS for child 
mortality prevention
The results for targeted conventional nets are shown in
Table 3, the cost per death averted ranged from USD 438
to USD 2,199. The cost per DALY averted was below USD
100 in all cases. Under scenarios with targeted LLINs with
three-year physical and protective lifetimes (Table 4), the
range of cost per death and DALY averted was lower than
in conventional ITN scenarios, although when re-treat-
ment benefits and commodity costs were excluded Tanza-
nia and Eritrea did not show cost-effectiveness
improvements. For targeted LLINs with five-year physical
and protective lifetimes (Table 5), the cost per death
averted in all cases showed cost-effectiveness improve-
ments when compared to the three-year LLIN scenarios.
For IRS, the cost per death averted ranged from USD 3,933
in Mozambique to USD 4,357 in KwaZulu-Natal (Table
3). The cost per DALY averted ranged from USD 119 to
USD 132.
LLINs, when targeted to high-risk groups in highly
endemic areas appear more cost-effective than conven-
tional nets and also more cost-effective than IRS delivered
population-wide. Interestingly, the only circumstances in
which LLINs did not clearly improve the cost-effectiveness
of treated net programmes were in Eritrea and Tanzania
(Figure 1). In Eritrea the initial commodity costs for nets
were substantially lower than in other settings and in both
countries the numbers of re-treatments delivered com-
pared to nets delivered was high.
Sensitivity analysis: usage of nets by children
A major difference between ITNs and IRS is that the latter
intervention cannot be targeted to high-risk demographic
groups (pregnant women and small children), since IRS
has to be applied to a large proportion of all houses in a
geographic area to be effective. This has implications for
total cost and also cost-effectiveness, which was explored
in a sensitivity analysis. In the base analysis, only one
child per net was allowed and it was assumed that only
50% of nets were used to protect children. In sensitivity
analysis this usage parameter had an important effect on
the cost-effectiveness of every ITN programme because it
altered the number of child years of protection provided
without changing the costs. At lower usage levels (below
20–30%), the cost-effectiveness of net programmes (espe-
cially with conventional nets) resembled that of IRS pro-
grammes [25].
An important element that is not considered here for lack
of reliable empirical evidence is how coverage of the inter-
vention relates to its health impact. So far, few large-scale
vector control programmes have been evaluated reliably
with regard to health impact. However, it is well described
that with ITN coverage above 50% there is a substantial
community effect [44,45], while impact is reduced at
lower coverage levels. Since all programmes aim at a high
coverage rate (60–80%) and since all reliable impact data
has been gathered under this level of coverage [37], it
seemed best to consider only one set of impact values.
Discussion
Main findings
These results confirm previous work showing that vector
control for malaria in sub-Saharan Africa is extremely
Table 5: Average annual economic costs for ITN (5-year LLIN) programmes.
ITN programme Average annual cost per 
LLIN distributed*
Average annual cost per 
TNY*
Cost per death averted* Cost per DALY averted*
Eritrea 10.08/9.60 1.38/1.92 502/698 15/21
Togo 3.23 1.90 692 21
Malawi 5.05/4.36 1.79/1.69 651/616 20/19
Senegal 7.36/6.96 1.67/3.25 606/1,181 18/36
Tanzania 5.74/5.06 1.62/2.28 588/828 18/25
* In paired numbers the left value includes protection from re-treatment kits while the right value results from removing both protection and 
commodity costs related to re-treatment kits (see main text for details).
Assumes all nets are long-lasting insecticidal nets (LLIN) with 5 years duration and a cost of USD 7. 2005 USD. TNY = treated net-year. DALY = 
disability-adjusted life year.
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cost-effective, as even with conservative assumptions the
cost per death averted was typically below USD 1,000 for
LLINs. Clearly, the move from conventional ITNs to LLINs
needs to be effected as soon as possible. In this review, all
major types of programmes were covered, with the excep-
tion of programmes distributing free LLINs to the whole
population (and not only special risk groups such as chil-
dren) – as promoted recently by WHO [28]. No such pro-
grammes had taken place at the time of this work and,
therefore, no data could be collected on this strategy.
Although the implications of such a large change in the
scale of ITN activities are difficult to quantify at present, it
should be possible to estimate the cost of such an
approach on the basis of this data.
In all programmes under review the cost per treated net-
year was surprisingly close in the LLIN scenarios, indicat-
ing that programme managers do have real options. How-
ever, cost-effectiveness is only one criterion for comparing
strategies and decision makers must also consider other
important aspects including: (1) the value of continuous
promotion (such as found in social marketing pro-
grammes) versus a more intermittent approach; (2) the
potential of a strategy to strengthen clinics/health facili-
ties and improve uptake of antenatal care or immuniza-
tion services; (3) the total cost of the strategy in relation to
available resources; (4) the equity implications of each
strategy; (5) which stakeholders and sectors bear the bur-
den of a given strategy; (6) the opportunity cost in relation
to other available health interventions.
It appears that the most cost-effective means of preventing
child deaths from malaria is through successfully targeting
LLINs to under-five children, while still achieving a rela-
tively high coverage in the rest of the population. If nets
were to only protect children little community effect
would be realized as children represent less than 20% of
the population in sub-Saharan Africa [45]. Under any sce-
nario these findings suggest that LLINs are more cost-
effective in high endemicity settings compared to IRS. In
areas of year round transmission, especially those with
limited physical and human infrastructure, LLINs are also
Cost-effectiveness results of shifting to long-lasting insecticidal netsFigur  1
Cost-effectiveness results of shifting to long-lasting insecticidal nets. Cost-effectiveness results of shifting to three-
year (USD 5) or five-year (USD 7) long-lasting insecticidal nets (LLINs) relative to conventional ITN estimates. LLIN CE esti-
mates do not include protection from re-treatment kits but may include some costs associated with their distribution (see 
main text).
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0
500
1000
1500
2000
2500
Eritrea Togo Malawi Senegal Tanzania
Program
20
05
U
SD
Conventional Nets 3 year LLIN 5 year LLIN
Malaria Journal 2008, 7:258 http://www.malariajournal.com/content/7/1/258
Page 9 of 12
(page number not for citation purposes)
likely to be more feasible than IRS. By contrast, IRS is
competitive with ITNs and may be the better option in
areas where few spray rounds are required due to either
short transmission seasons, the use of inexpensive but
long lasting insecticides (such as DDT), or in epidemic
prone areas and other situations where good geographic
and temporal targeting is possible [46].
Economies of scale and scope need to be considered, as
they may have significant effects on the unit cost per ITN
by creating efficiencies within the supply chain or by
improving demand through the integration of ITN deliv-
ery or promotion with a wider range of desirable products
or services. In this study, the effects were found to be com-
plex and not clearly present in all reviewed programmes.
In Malawi this effect is well documented and the cost per
unit in the 5th year of operation fell to approximately 30%
of the first year [14]. To some extent, differences in scope
and scale may also confound these comparisons given the
large differences in the operational scale of each pro-
gramme as well as relative to the context in which they
operate.
Limitations in the comparability of vector control 
programmes
In making inter-country comparisons, uncontrollable dif-
ferences in infrastructure, society, culture, and other vari-
ables can induce bias. This study presents selected case
studies believed to be representative of different ITN and
IRS programmes and delivery approaches in sub-Saharan
Africa. However, there may be significant variations in the
performance and costs of implementation of these strate-
gies in other settings. Also, in comparing cost information
other limitations inevitably arise because of the nature
and timing of large scale implementation. For example, it
was not possible to compare data sets corresponding to
the exact same time period, either temporally or in the his-
tory of the programme, nor was it possible to completely
control for differences in the scale of programmes. Simi-
larly, it was not possible to control perfectly for variations
in price level, although all five ITN countries fit the World
Bank definition of a low-income country (GNI per capita
below USD 905 in 2006). New country-specific impact
data at varying levels of coverage and over the long-term
could improve the impact predictions, although ulti-
mately all malaria vector control programmes will aim
towards a high coverage of LLINs and hence these differ-
ences might not ultimately be marked. Additionally, only
the economic costs of programmes are presented here and
though this can give guidance in and towards the selection
of strategies, decisions must be made in each setting, in
the light of both ecological and epidemiological factors as
well as local health systems and resources.
Health system effects
Prevention of malaria can lead to a drastic reduction in
the number of patients in health facilities, reducing pres-
sure on over-stretched health facilities and thus benefit
the whole health system. The provision of free or low-cost
nets at health facilities (through vouchers or as a direct
donation) may also be an enticement to pregnant women
and mothers to use preventive services. In Malawi a por-
tion of income received from the sale of highly subsidized
nets is retained at the facility level and may act as an incen-
tive for staff. On the other hand, comprehensive vector
control programmes can burden weak health systems
with new activities and lead to additional problems.
ITN programmes with their range of strategic options and
possible interactions with non-health sectors appeared
more flexible in their demands on the health system than
the IRS programmes examined – though some recent IRS
programmes, in Bioko Island, Uganda, and Zanzibar have
shown that this burden may be shifted to NGOs or com-
mercial organizations [47]. In any case, vector control
scale-up requires a capacity expansion in the preventive
health care delivery sector. All of the ITN case studies
examined here depended to some extent on public sector
involvement (though levels of public input were highly
variable). Table 6 attempts to summarize qualitatively the
demands of the seven vector control programmes on three
sectors (public, commercial, non-governmental) based on
the results of interviews, document reviews and costing. In
the case of the two programmes with a high commercial
sector involvement (Tanzania and Senegal), reliance on
this sector comes with profit incentives for the actors
involved.
Table 6: Level of involvement of public, private and non-governmental (NGO) sectors in vector control programmes.
Programme Public sector Commercial sector NGO sector
Eritrea  
Togo  
Malawi   
Senegal   
Tanzania   
KwaZulu-Natal 
Mozambique   
Malaria Journal 2008, 7:258 http://www.malariajournal.com/content/7/1/258
Page 10 of 12
(page number not for citation purposes)
IRS programmes require a high level of expertise in ento-
mology and management, which might put overwhelm-
ing demands to public systems in the face of the generally
low availability of trained personnel in many endemic set-
tings. However, a programme can also help to develop
local capacity in these areas. The South African example
has demonstrated the many ways in which vector control
programmes can contribute not only to the reduction of
disease but also to the development of local capacity and
the training of technicians and scientists.
Coverage and timing
Major differences were seen in both the levels of coverage
achieved in the various ITN programmes, as well as in the
duration of time that was required to achieve these cover-
age levels, or alternatively the time over which they were
able to maintain coverage levels. The coverage levels
achieved generally correlated with the price charged to
users for ITNs: those programmes which delivered nets to
users freely achieving the highest measured coverage lev-
els and those with user charges reporting lower coverage
and usage. The time to achieve increases in coverage was
also generally much faster in programmes without user
charges, but only one programme, Eritrea's, allowed for
the examination of the long term implications of main-
taining coverage with no user charges. While coverage in
Eritrea has been successfully maintained for several years
without user charges the overall cost per ITN was higher
than in several other programmes. The free ITN pro-
grammes appeared to be highly effective at achieving
higher coverage more quickly than those with user
charges, while maintaining lower or competitive cost-
effectiveness.
"Catch-up" versus "keep-up"
Currently, there is a consensus for ITNs that both "catch-
up" (to rapidly increase ITN coverage) and "keep-up" (to
maintain high ITN coverage) strategies are required in
each country [2,48]. Integrated vaccination/ITN cam-
paigns such as those carried out in Togo (studied here),
Mozambique, Niger and other settings have achieved
good coverage rates (50–60%) within a short period of
time [21,49]. Such campaigns can therefore be seen as
serving the initial need for "catch-up" in ITN usage levels.
However, there is also a strong need for "keep-up" pro-
grammes to maintain high net usage levels, especially in
newly pregnant women and newborns. Three of the ITN
programmes reviewed tended to represent "keep-up"
strategies (Malawi, Senegal, Tanzania) while one (Eritrea)
mixed both. Recent work in Ghana [49,50] and on the
Kenyan ITN programme [51] have highlighted the com-
plementarity of both "catch up" and "keep-up"
approaches in achieving high ITN coverage and impres-
sive health impact. Further information and effort will be
required to determine which methods can be the most
effective and cost-effective to "keep-up" coverage over
time.
Financing
None of the ITN programmes appear to be independently
financially sustainable. Even the largely commercial sys-
tems, such as the SMARTNET programme in Tanzania or
the NetMark programme in Senegal, had substantial
donor input and would be unlikely to continue operating
at the same scale without continuing donor funding.
However, all the programmes under review appeared to
be operationally feasible and sustainable in the presence
of continued funding. Additionally, in terms of financing,
particular attention should be paid to pure provider costs
which are more reflective of the inputs of programmes,
donors or health ministries because they exclude costs
which are borne specifically by users. These costs were
similar across the ITN programmes examined here [25].
Conclusion
These findings confirm that large-scale delivery of ITNs
and IRS in sub-Saharan Africa is feasible and highly cost-
effective using a range of strategies. Delivery of LLINs
through campaigns provides a highly cost-effective and
achievable method for rapidly improving ITN coverage.
However, many other options exist for ITN programming,
some well suited to maintain coverage levels after cam-
paigns. IRS, or a combination of ITNs and IRS, remain
attractive and viable options in some settings. Given that
sustainable high-level funding appears to be available in
the long-term through new global financing mechanisms,
every malaria endemic country should aim to upscale
their vector control programmes as rapidly and sustaina-
bly as possible.
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